Equity - Schedule of Common Stock Warrants Granted and Outstanding (Details) |
9 Months Ended |
|---|---|
|
Sep. 30, 2018
$ / shares
shares
| |
| Stockholders' Equity Note [Abstract] | |
| Warrants Outstanding, Beginning balance | 35,087,198 |
| Warrants Outstanding, Granted | 17,454,666 |
| Warrants Outstanding, Exercised | (2,910,000) |
| Warrants Outstanding, Expired | (4,900,000) |
| Warrants Outstanding, Ending balance | 44,731,864 |
| Weighted Average Exercise Price, Beginning balance | $ / shares | $ 0.24 |
| Weighted Average Exercise Price, Granted | $ / shares | 0.11 |
| Weighted Average Exercise Price, Exercised | $ / shares | 0.10 |
| Weighted Average Exercise Price, Expired | $ / shares | $ 0.09 |
| Weighted average remaining contractual life (years), Beginning balance | 2 years 1 month 24 days |
| Weighted average remaining contractual life (years), Granted | 1 year 11 months 1 day |
| Weighted average remaining contractual life (years), Ending balance | 1 year 2 months 1 day |
| X | ||||||||||
- Definition Weighted Average Exercise Price, Expired. No definition available.
|
| X | ||||||||||
- Definition Warrants Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life (years), Granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life (years), Beginning balance. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life (years), Ending balance. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|